DE:7AL0 Stock Latest News
Company AnnouncementsNomination Committee Proposes Smaller Alligator Board, Lower Fees1d ago
Company AnnouncementsAlligator Bioscience Appoints Nomination Committee for 2027 AGM1w ago
Company AnnouncementsAlligator Bioscience Sells Mitazalimab Rights to Biossil in Strategic Refocus on HLX222w ago- Company AnnouncementsAlligator Bioscience Boosts Share Count After Rights Issue2w ago
Company AnnouncementsAlligator Bioscience Plans 1-for-1,000 Reverse Share Split and Warrant Term Adjustments2w ago
Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Share Capital and Board2w agoCompany AnnouncementsAlligator Bioscience to Present Q3 HER2-Focused Interim Report on 22 October1M ago
Company AnnouncementsAlligator Bioscience Names CFO Johan Giléus as CEO Amid Strategic Refocus on HLX221M ago
Company AnnouncementsAlligator Bioscience Restructures Fenja Loan With Directed Warrant Issue1M ago- Company AnnouncementsAlligator Bioscience’s Rights Issue Heavily Reliant on Guarantees, Triggers Major Dilution1M ago
- Company AnnouncementsAlligator Bioscience’s Rights Issue Undersubscribed, Underwriters Step In1M ago
Company AnnouncementsAlligator Bioscience Launches SEK 125.6 Million Rights Issue to Refocus Oncology Pipeline2M agoCompany AnnouncementsAlligator Bioscience Restructures Capital and Launches Major Rights Issue2M ago
Company AnnouncementsAlligator Bioscience exits mitazalimab development to refocus on HLX22 royalties and recapitalisation2M ago
- Company AnnouncementsAlligator Bioscience Schedules August Earnings Call Amid Strategic Refocus2M ago
- Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Capital and Approve Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Shifts Focus to HLX22 and Launches SEK 125.6 Million Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Backs Intratumoral Mitazalimab Study in Early Breast Cancer4M ago
Company AnnouncementsAlligator Bioscience Sees Revenue Upside as HLX22 Global Phase 3 Reaches Key Milestone5M ago
Company AnnouncementsAlligator Bioscience Sees Long-Term Revenue Potential in Henlius’ HLX22 Progress5M ago
Company AnnouncementsAlligator Bioscience AGM Backs Loss Carryforward and Expands Capital-Raising Mandate6M ago